Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (81-90 of 393) with videos related to

Pageof 40
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Factor Xa inhibitors: today and beyondJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2012
A comparison of the pharmacodynamic behavior of branded and biosimilar enoxaparin in primatesWalter Jeske, Evangelos Litinas, Hussein Khan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 8, 2012
Assessment of levels of vascular endothelial growth factor in patients with ESRD and its possible role in cardiovascular morbidity and mortalityIndermohan Thethi, Vinod Bansal, Hussein Khan, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 1, 2022
Bridging The Diabetic Microvascular and Macrovascular Gap In Peripheral Arterial DiseaseJake Goldstein, Jawed Fareed, Carlos F Bechara, et al.
Hematology/Oncology Clinics of North America|March 12, 2003
Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiationDebra Hoppensteadt, Jeanine M Walenga, Jawed Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 7, 2012
Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal diseaseKorosh Sharain, Debra Hoppensteadt, Vinod Bansal, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Heparin to pentasaccharide and beyond: the end is not in sightHarry L Messmore, William H Wehrmacher, Erwin Coyne, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implicationNasiredin Sadeghi, Daniel Kahn, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal diseaseKristiyana Kaneva, Vinod Bansal, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 18, 2019
Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular CoagulationPriya Patel, Amanda Walborn, Matthew Rondina, et al.
Pageof 40

Showing results (81-90 of 393) with videos related to

Sort By:
Pageof 40
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Factor Xa inhibitors: today and beyondJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2012
A comparison of the pharmacodynamic behavior of branded and biosimilar enoxaparin in primatesWalter Jeske, Evangelos Litinas, Hussein Khan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 8, 2012
Assessment of levels of vascular endothelial growth factor in patients with ESRD and its possible role in cardiovascular morbidity and mortalityIndermohan Thethi, Vinod Bansal, Hussein Khan, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 1, 2022
Bridging The Diabetic Microvascular and Macrovascular Gap In Peripheral Arterial DiseaseJake Goldstein, Jawed Fareed, Carlos F Bechara, et al.
Hematology/Oncology Clinics of North America|March 12, 2003
Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiationDebra Hoppensteadt, Jeanine M Walenga, Jawed Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 7, 2012
Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal diseaseKorosh Sharain, Debra Hoppensteadt, Vinod Bansal, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Heparin to pentasaccharide and beyond: the end is not in sightHarry L Messmore, William H Wehrmacher, Erwin Coyne, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implicationNasiredin Sadeghi, Daniel Kahn, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal diseaseKristiyana Kaneva, Vinod Bansal, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 18, 2019
Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular CoagulationPriya Patel, Amanda Walborn, Matthew Rondina, et al.
Pageof 40